Pricing Log in Create free account

Apnimed, Inc. (APMD) vs Olema Pharmaceuticals, Inc. (OLMA)

Apnimed, Inc. and Olema Pharmaceuticals, Inc. are both Biotechnology companies. Apnimed, Inc. and Olema Pharmaceuticals, Inc. are of similar size ($591.5M and $589.5M). Olema Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Apnimed, Inc. trades at 0.8×. Apnimed, Inc. has the higher net margin (81.6% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Apnimed, Inc. leads on 8 and Olema Pharmaceuticals, Inc. on 4.

Valuation

Metric APMD OLMA Biotechnology median
P/E 0.76 n/m 10.60
P/S 0.62 n/m 9.40
P/B n/m 1.77 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales (0.18) n/m 9.02
Earnings yield 130.86% (29.04%) (32.88%)
Free cash flow yield (115.77%) (21.63%) (23.13%)

Profitability

Metric APMD OLMA Biotechnology median
Gross margin 94.53% 0.00% 68.51%
Operating margin 19.88% 0.00% 0.00%
Net margin 81.56% 0.00% 0.00%
Free cash flow margin (71.50%) 0.00% 0.00%
Return on equity 0.00% (52.74%) (51.96%)
Return on assets 0.00% (47.10%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APMD OLMA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (14.69%) 15.00% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric APMD OLMA Biotechnology median
Debt to equity (0.45) 0.01 0.00
Current ratio 5.19 8.86 4.97
Net debt to EBITDA 0.02 2.82 1.01

Dividend

Metric APMD OLMA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric APMD OLMA Biotechnology median
Market cap 589.49m 591.48m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack